Man Group PLC Kempharm, Inc Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.13 - $6.27 $43,455 - $65,972	-10,522 Reduced 31.84%	22,524 $123,000
Q4 2022 Feb 14, 2023	BUY	$4.12 - $5.62 $15,524 - $21,176	3,768 Added 12.87%	33,046 $151,000
Q3 2022 Nov 14, 2022	SELL	$4.5 - $6.85 $170,973 - $260,258	-37,994 Reduced 56.48%	29,278 $183,000
Q2 2022 Aug 15, 2022	BUY	$4.02 - $5.21 $270,433 - $350,487	67,272 New	67,272 $300,000

117

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.